Vitro Biopharma, Inc. Annual Operating Lease, Payments in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vitro Biopharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2022 to 2023.
  • Vitro Biopharma, Inc. Operating Lease, Payments for the quarter ending January 31, 2024 was $56.9K, a 11.1% increase year-over-year.
  • Vitro Biopharma, Inc. annual Operating Lease, Payments for 2023 was $134K, a 8.31% decline from 2022.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $134K -$12.1K -8.31% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 $146K Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.